Genetic modifiers of neurological disease

Jennifer A. Kearney

doi:10.1016/j.gde.2010.12.007

Genetic modifiers of neurological disease

Jennifer A. Kearney^*

^*Corresponding author for this work

Pharmacology

Research output: Contribution to journal › Review article

22 Scopus citations

Abstract

Genetic modifiers make an important contribution to neurological disease phenotypes. Significant progress has been made by studying genetic modifiers in model organisms. The ability to study complex genetic interactions in model systems contributes to our understanding of the genetic factors that influence neurological disease. This will lead to the development of novel therapeutic strategies and personalized treatment based on genetic risk.

Original language	English (US)
Pages (from-to)	349-353
Number of pages	5
Journal	Current Opinion in Genetics and Development
Volume	21
Issue number	3
DOIs	https://doi.org/10.1016/j.gde.2010.12.007
State	Published - Jun 1 2011

ASJC Scopus subject areas

Genetics
Developmental Biology

Access to Document

10.1016/j.gde.2010.12.007

Fingerprint Dive into the research topics of 'Genetic modifiers of neurological disease'. Together they form a unique fingerprint.

Cite this

Kearney, J. A. (2011). Genetic modifiers of neurological disease. Current Opinion in Genetics and Development, 21(3), 349-353. https://doi.org/10.1016/j.gde.2010.12.007

@article{65e73bf02b2a419ab6d5d0cf7ebc4f6c,

title = "Genetic modifiers of neurological disease",

abstract = "Genetic modifiers make an important contribution to neurological disease phenotypes. Significant progress has been made by studying genetic modifiers in model organisms. The ability to study complex genetic interactions in model systems contributes to our understanding of the genetic factors that influence neurological disease. This will lead to the development of novel therapeutic strategies and personalized treatment based on genetic risk.",

author = "Kearney, {Jennifer A.}",

year = "2011",

month = jun,

day = "1",

doi = "10.1016/j.gde.2010.12.007",

language = "English (US)",

volume = "21",

pages = "349--353",

journal = "Current Opinion in Genetics and Development",

issn = "0959-437X",

publisher = "Elsevier Limited",

number = "3",

}

TY - JOUR

T1 - Genetic modifiers of neurological disease

AU - Kearney, Jennifer A.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Genetic modifiers make an important contribution to neurological disease phenotypes. Significant progress has been made by studying genetic modifiers in model organisms. The ability to study complex genetic interactions in model systems contributes to our understanding of the genetic factors that influence neurological disease. This will lead to the development of novel therapeutic strategies and personalized treatment based on genetic risk.

AB - Genetic modifiers make an important contribution to neurological disease phenotypes. Significant progress has been made by studying genetic modifiers in model organisms. The ability to study complex genetic interactions in model systems contributes to our understanding of the genetic factors that influence neurological disease. This will lead to the development of novel therapeutic strategies and personalized treatment based on genetic risk.

UR - http://www.scopus.com/inward/record.url?scp=79957583944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957583944&partnerID=8YFLogxK

U2 - 10.1016/j.gde.2010.12.007

DO - 10.1016/j.gde.2010.12.007

M3 - Review article

C2 - 21251811

AN - SCOPUS:79957583944

VL - 21

SP - 349

EP - 353

JO - Current Opinion in Genetics and Development

JF - Current Opinion in Genetics and Development

SN - 0959-437X

IS - 3

ER -